BMW Group has partnered with the Regional Center of Excellence for Robotic Technology (CRTA) at the University of Zagreb to ...

BMW Group is partnering with the Centre of Excellence for Robotic Technology (CRTA) at the University of Zagreb in Croatia to ...

CellProthera will use Quintessence’s DACSTM flotation‑based cell sorting platform for its potential to enhance therapeutic purity and preserve stem cell phenotype for CD34+-based cell therapy Mulhouse ...

BMW Group and University of Zagreb are advancing battery cell production using artificial intelligence through the “Insight” ...

BMW Group says new AI models developed with the University of Zagreb can cut ...

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, producing cell aggregates in bioreactors is highly complex and cost-intensive.

Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot ...

Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer study PHILADELPHIA and MELBOURNE, ...